A carregar...
Potential role for mammalian target of rapamycin inhibitors as first-line therapy in hormone receptor–positive advanced breast cancer
Despite advances in cytotoxic chemotherapy and targeted therapies, 5-year survival rates remain low for patients with advanced breast cancer at diagnosis. This highlights the limited effectiveness of current treatment options. An improved understanding of cellular functions associated with the devel...
Na minha lista:
| Publicado no: | Onco Targets Ther |
|---|---|
| Autor principal: | |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Dove Medical Press
2015
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4676614/ https://ncbi.nlm.nih.gov/pubmed/26675495 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OTT.S88037 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|